264 related articles for article (PubMed ID: 17133598)
1. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1.
Pullerits R; Brisslert M; Jonsson IM; Tarkowski A
Arthritis Rheum; 2006 Dec; 54(12):3898-907. PubMed ID: 17133598
[TBL] [Abstract][Full Text] [Related]
2. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine.
Taniguchi N; Kawahara K; Yone K; Hashiguchi T; Yamakuchi M; Goto M; Inoue K; Yamada S; Ijiri K; Matsunaga S; Nakajima T; Komiya S; Maruyama I
Arthritis Rheum; 2003 Apr; 48(4):971-81. PubMed ID: 12687539
[TBL] [Abstract][Full Text] [Related]
3. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis.
Pullerits R; Jonsson IM; Verdrengh M; Bokarewa M; Andersson U; Erlandsson-Harris H; Tarkowski A
Arthritis Rheum; 2003 Jun; 48(6):1693-700. PubMed ID: 12794838
[TBL] [Abstract][Full Text] [Related]
4. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
5. Intra-peritoneal sRAGE treatment induces alterations in cellular distribution of CD19(+), CD3 (+) and Mac-1 (+) cells in lymphoid organs and peritoneal cavity.
Brisslert M; Amu S; Pullerits R
Cell Tissue Res; 2013 Jan; 351(1):139-48. PubMed ID: 23086479
[TBL] [Abstract][Full Text] [Related]
6. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.
Zeng S; Feirt N; Goldstein M; Guarrera J; Ippagunta N; Ekong U; Dun H; Lu Y; Qu W; Schmidt AM; Emond JC
Hepatology; 2004 Feb; 39(2):422-32. PubMed ID: 14767995
[TBL] [Abstract][Full Text] [Related]
7. Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.
Zhang H; Tasaka S; Shiraishi Y; Fukunaga K; Yamada W; Seki H; Ogawa Y; Miyamoto K; Nakano Y; Hasegawa N; Miyasho T; Maruyama I; Ishizaka A
Am J Respir Crit Care Med; 2008 Aug; 178(4):356-62. PubMed ID: 18535257
[TBL] [Abstract][Full Text] [Related]
8. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
[TBL] [Abstract][Full Text] [Related]
9. High mobility group box protein-1 in experimental autoimmune uveoretinitis.
Watanabe T; Keino H; Sato Y; Kudo A; Kawakami H; Okada AA
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2283-90. PubMed ID: 19151394
[TBL] [Abstract][Full Text] [Related]
10. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
[TBL] [Abstract][Full Text] [Related]
11. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
12. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
Allmen EU; Koch M; Fritz G; Legler DF
Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
[TBL] [Abstract][Full Text] [Related]
13. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
van Beijnum JR; Buurman WA; Griffioen AW
Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
[TBL] [Abstract][Full Text] [Related]
14. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
[TBL] [Abstract][Full Text] [Related]
15. Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products.
Okamoto H; Katagiri Y; Kiire A; Momohara S; Kamatani N
J Rheumatol; 2008 May; 35(5):752-6. PubMed ID: 18322992
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end product receptor-mediated cellular dysfunction.
Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
19. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
